Clinical data | |
---|---|
Routes of administration | By mouth, under the tongue |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C24H29N3O2 |
Molar mass | 391.515 g·mol−1 |
3D model (JSmol) | |
| |
|
1cP-LSD (N1-(cyclopropylmethanoyl)-lysergic acid diethylamide) is an acylated derivative of lysergic acid diethylamide (LSD), which has been sold as a designer drug. [1][2] In tests on mice it was found to be an active psychedelic with similar potency to 1P-LSD.[3]
Sweden's public health agency suggested classifying 1cP-LSD as a dangerous substance on 18 December 2019 and later classified it as such on 22 April 2021.[4][5]
Lysergic acid derivatives |
|
---|---|
Psychedelic lysergamides |
|
Clavines | |
Other ergolines | |
Natural sources |
Morning glory: Argyreia nervosa (Hawaiian Baby Woodrose), Ipomoea spp.(Morning Glory, Tlitliltzin, Badoh Negro), Rivea corymbosa (Coaxihuitl, Ololiúqui) |